Invasive Ductal Breast Carcinoma Recruiting Phase 3 Trials for Fulvestrant (DB00947)

Also known as: Invasive Ductal Breast Cancer / Carcinoma, Ductal, Breast / Infiltrating ductular carcinoma / Breast ductal cancer invasive / Breast ductal cancer infiltrating / Infiltrating ductal breast cancer

IndicationStatusPhase
DBCOND0047004 (Invasive Ductal Breast Carcinoma)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01953588Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing SurgeryTreatment